Endometrial Cancer Trial, Recruiting NCT07526311 Sponsor: Cairo University Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07526311
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between the ages of 25 and 48 years
  • People with a body mass index (a measure of body weight relative to height) below 35
  • People who have uterine fibroids (non-cancerous growths in the womb) that are causing symptoms and have been recommended for surgery
  • People whose fibroids are located within the muscular wall of the womb, classified as a specific type (FIGO types 3 to 6) — (confirm with trial site if unsure which type applies)
  • People whose fibroids have been confirmed by an internal ultrasound scan and/or an MRI scan
  • People whose largest fibroid measures 20 centimetres or less across
  • People who are already scheduled for a planned open abdominal surgery to remove fibroids (called a transabdominal myomectomy)
  • People who are willing and able to sign a written consent form

Who may not be able to join:

  • People whose fibroids are located just beneath the inner lining of the womb, inside the womb cavity, on a stalk on the outer surface of the womb, on the cervix, or near the ovaries
  • People whose fibroids are classified as FIGO types 0, 1, 2, 7, or 8 — (confirm with trial site if unsure which type applies)
  • People who have had a past infection or inflammation involving the pelvis or abdomen (such as pelvic inflammatory disease or peritonitis)
  • People who have previously had abdominal or pelvic surgery for reasons unrelated to childbirth
  • People who have previously had any surgery on their womb
  • People who have used hormone-based treatments within the past three months
  • People with a known disorder affecting blood clotting or bleeding
  • People who are currently taking blood-thinning or clot-preventing medications
  • People whose pre-surgery blood count shows a haemoglobin level below 10 g/dL, indicating anaemia — (confirm with trial site)
  • People whose body mass index is 35 or above
  • People whose surgery changes during the operation from fibroid removal to full removal of the womb (hysterectomy)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01090013685

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 April 2026
Est. completion
10 March 2027

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Estimated blood loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov